Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers
NCT00565708Phase 3Active, not recruiting
- Sponsor
- National Cancer Centre Singapore
- Start
- Dec 2008
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands
- Countries
- 10
01
Overview
A Phase 3 trial of aspirin in colorectal cancer (CRC), sponsored by National Cancer Centre Singapore. Started Dec 2008; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00565708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00565708.